Georges F. Hatoum, M.D.
Dr Lesnikoski is the Medical Director of the Breast Institute at JFK Medical Center, in Atlantis Florida. She attended Yale University for her BA in Architecture, and then Temple University School of Medicine. She completed her General Surgery training at New England Deaconess/Harvard Surgical Service and went on to a specialized Fellowship in Diseases of the Breast at the Faulkner BreastCare Center in Boston in 1996. She was an Attending Breast Surgeon at Beth Israel Deaconess Medical Center from 1996-2001, and then moved to Brigham and Women's Hospital, Faulkner Hospital - Dana Farber Cancer Institute in Boston between 2001-2011. She founded the South Shore Hospital Breast Care Center in 2001, and was Medical Director there through 2008. Dr Lesnikoski is invited to speak around the U.S. because of her experience in developing interdisciplinary breast and cancer programs at multiple institutions throughout her career. In 2009, she founded The Breast Institute at JFK Medical Center, the only breast program in Florida recognized by the National Quality Measures for Breast Centers (NQMBC) as a Certified Quality Breast Center. The Breast Institute was accredited by the National Accreditation Program for Breast Centers (NAPBC) in 2010. Dr Lesnikoski became a surveyor for NAPBC in 2011. Dr Lesnikoski specializes in oncoplastic breast surgery and innovative approaches to breast cancer treatment. She is a Voluntary Clinical Assistant Professor of Surgery at the University of Miami Miller School of Medicine. She is passionate about educating both patients and physicians in the most up to date approaches to breast care. In 2012, she was honored by Project Access of the Palm Beach Medical Society, for her outreach work to the underserved community. CLINICAL FELLOWSHIP Diseases of the Breast Faulkner Breast Center, Faulkner Hospital, Boston, MA RESEARCH FELLOWSHIP Fellow in Surgical Research, Transplantation Immunology Sandoz Center for Immunobiology, Boston, MA< ACADEMIC APPOINTMENTS Voluntary Clinical Assistant Professor, University of Miami
Dr Georges F. Hatoum is the Medical Director of the JFK Comprehensive Cancer Institute. He obtained his medical degree with honors from the Lebanese University, Faculty of Medical Sciences. His residency was completed at the Syracuse Upstate Medical University with rotations at the University of Miami and Sloan-Kettering Cancer Center. He was then appointed as the Chief of Radiation Oncology at the Stratton VA Medical Center, Albany, NY where he carried an appointment as Assistant Professor of Medicine. From 2006-2010, Dr Hatoum worked at the Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine. Dr Hatoum carried different appointments including Associate Professor of Clinical Radiation Oncology, co-leader of the head and neck cancer site disease group as well as Associate Director of Radiation Oncology at Jackson Memorial Hospital. During his professorship at the University of Miami, Dr Hatoum was chosen as the 2009 ARRO teacher of the year award winner, America's top Radiation Oncologists by the Research Council of America, as well as the Osler Institute award winner of Excellence in Teaching. He was also the local principal investigator for different RTOG as well as pharmaceutical trials. Dr Hatoum joins JFK as the newly appointed Medical Director of Radiosurgery and Radiation Oncology. He also carries an appointment as an Affiliate Associate Professor of Clinical Biomedical Science at Charles E. Schmidt College of Medicine at FAU. Recent Publication Books and monographs published: 1. Sagerman RH, Hatoum GF, Hahn SS. Optic Pathway Glioma. Radiotherapy of intraocular and orbital tumors. Springer, 2002: 137-144. 2. Hatoum GF, Wen B-C. Meningioma. In: Radiation Oncology: An Evidence-based Approach, Jiade J. Lu and Luther W. Brady Eds, Springer, 2008: 473-481. 3. Takita C, Hatoum GF. Pediatric Central Nervous System Tumors. In: Radiation Oncology: An Evidence-based Approach, Jiade J. Lu and Luther W. Brady Eds, 2008: 548-555. Juried or refereed journal articles or exhibitions: 1. Hatoum GF, Nevaldine B., Bhavsar T., and Hahn P.J., Wr-1065, the active form of amifostine, protects hl-60 cells but not peripheral blood mononuclear cells from radiation and etoposide-induced apoptosis. International Journal of Radiation Oncology Biology Physics, (59): 844-851, 2004 2. Hatoum GF, Patton B, Takita C, Abdel-Wahab M, Lafave K, Weed D, Reis I . Small Cell Carcinoma of the Head and Neck: The University of Miami Experience, Int. J. Radiation Oncology Biol. Phys., 74(2):477-481, 2009 3. Hatoum GF, Abitbol A, Elattar I, and Abdel-Wahab M. Radiation Technique Influence on PEG Tube Dependence: Comparison between Two Radiation Schemes, Head and Neck, 31(7):944-948, 2009. 4. Bastos B, Hatoum GF, Raez LE, Waker G. Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer, Journal of Thoracic Oncology, 5(4):533-539, 2010 5. Neskey D, Hatoum G, et al. Outcomes after Surgical Resection of Head and Neck Paragangliomas, Skull Base 21(3): 171-176, 2011